Ahead of Covid vaccine, government & companies stock up vials, syringes
Since most companies would trade through government institutions and not the private market, they are going for multi-dose vials which will bring down the number of units required.
Synopsis
To meet that demand, pharma companies, which are working on the potential vaccine candidate for Covid-19, have started tying up with manufacturers of vials and the rubber stoppers that are used in the vials.
To Read the Full Story, Become an ET Prime Member
Access the exclusive Economic Times stories, Editorial and Expert opinion
Why
Sharp Insight-rich, Indepth stories across 20+ sectors
Access the exclusive Economic Times stories, Editorial and Expert opinion
- Clean experience with
Minimal Ads - Comment & Engage with ET Prime community
- Exclusive invites to Virtual Events with Industry Leaders
- A trusted team of Journalists & Analysts who can best filter signal from noise